Quick Summary
• Among the emerging applications of 3D printing in healthcare, regenerative soft tissue reconstruction has seen the least clinical progress and carries some of the highest unmet patient need. Every year, hundreds of thousands of women undergo lumpectomy, the surgical removal of a cancerous breast tumor, and the majority walk away cancer-free. What many also walk…
Additional Context
Among the emerging applications of 3D printing in healthcare, regenerative soft tissue reconstruction has seen the least clinical progress and carries some of the highest unmet patient need.
Every year, hundreds of thousands of women undergo lumpectomy, the surgical removal of a cancerous breast tumor, and the majority walk away cancer-free. What many also walk away with permanently is a contour deformity. For most of these patients, there is simply no good reconstructive option available.
GenesisTissue Inc., an early-stage biotechnology research company, is trying to change that. Their lead product, Regenerative Breast Tissue (RBT), is a bioprinted, personalized, biodegradable synthetic scaffold designed to fill a soft tissue void, support a fat graft, and ultimately make way for the bo